Register for IPO Updates
US IPO Stats
IPO Industry Breakdown
Largest Global IPOs
Largest US IPOs
IPO News Archive
New Ways to Invest in IPOs - IPO ETFs
US IPO Week Ahead: China's ZTO Express delivers largest IPO of 2016 in a 6-deal week
Analyst IPO Market Commentary
Six companies are on the
US IPO calendar
to raise $2.2 billion in the week ahead, or $2.6 billion including a large SPAC. October is set to surpass September as the year's most active month for IPOs. Filing activity has slowed heading into November, as expected.
2 big IPOs:
combines strong sales ($1.2B), growth (+70%) and margins (25% EBIT)
sells the world's leading golf brands, Titleist and FootJoy
2 high-growth tech
: Silver Lake SaaS
and Sequoia-backed chip maker
: Hedge fund-backed
The world's top institutional investors use Renaissance Capital's
Follow us on Twitter (
) for IPO news as it happens and
register for our updates
on the IPO market.
Renaissance Capital's IPO Calendar - Week of 10/24/2016
$16.50 - $18.50
Goldman Sachs (Asia)
Leading Chinese express delivery company.
$21.00 - $24.00
Manufactures and markets golf equipment under several brands (e.g. Titleist).
$12.00 - $15.00
Cowen & Company
Newly-formed biotech developing an acquired therapy for endocrine disorders.
Woodland Hills, CA
$13.00 - $15.00
Provides a cloud-based platform for automating financial reporting.
$14.00 - $16.00
Fabless designer of next-generation chipsets for high-speed Wi-Fi networks.
$12.00 - $14.00
BMO Capital Markets
Developing small molecule therapies for rare immune disorders.
GTY Technology Holdings
Las Vegas, NV
$10.00 - $10.00
Blank check company formed by the former CEOs of Accenture and EMC to acquire a technology business.
$7.00 - $9.00
Joseph Gunnar & Co.
Develops and sells products used to create private cellular networks.
Chinese delivery company set to deliver year's largest IPO
) planned $1.2 billion IPO makes it the year's largest to date, and the largest US IPO from a Chinese company since Alibaba (
) in September 2014. Similarly, ZTO is a direct play on China's growing e-commerce market, and 77% of its parcel volume consists of items ordered from Alibaba. That concentration is a notable risk, and while the shipper's volumes have picked up, revenue per parcel could continue to drop off. That said, ZTO ticks all the boxes that are part and parcel of a solid IPO, as a highly profitable market leader that is taking share in an industry with strong secular growth.
Titleist is teed up
) is set to raise $435 million, all from private equity shareholders. The company offers the world's #1 golf ball (Titleist) as well as the #1 golf shoe and glove (FootJoy). It also boasts an experienced management team and generates more than enough cash to cover its planned 2.1% dividend. Potential hazards include the widespread decline in golfers over the past decade, which contributed to sales declining 2% in 2015.
A double dose of high-growth tech
The week's two tech IPOs both plan to raise over $100 million, a feat achieved by just six tech IPOs this year. If not for ZTO, either deal could have headlined this week's offerings, with 2016 tech IPOs up 56% on average.
) is set to raise $120 million to pay down debt and fund its rapid expansion. Its automated financial reporting software is used by over 150,000 people worldwide. The company grew about 50% in the most recent quarter, and while BlackLine is still in the red on EBITDA, it recently turned free cash flow positive. Backed by Silver Lake and ICONIQ (buying 10% of the IPO), BlackLine's valuation is being pitched below high-growth SaaS peers.
) is eyeing a $101 million IPO in the week ahead. The fabless semiconductor company has raised over $160 million from venture firms, including Sequoia Capital, RUSNANO and Venrock. Its chipsets help power Wi-Fi networks, and are considered some of the most advanced on the market, helping to drive 56% growth in the most recent quarter. Like many semiconductor IPOs, it has high customer concentration and will challenge much larger competitors.
Hedge funds bring year's largest biotech IPO; strong VCs behind the other
) is looking to raise $176 million to take an acquired therapy to the finish line. Its deal size would make it the year's largest IPO from a biotech, and it is also the youngest, having been formed eight months ago by the same hedge fund backers that brought
) public last year. Pitched at a valuation of about $800 million, Myovant is led by the former CMO of Medivation, and its board includes the ex-CFO of Anthem and the former US Secretary of Health and Human Services, Kathleen Sebelius.
) plans to raise $75 million to take its lead candidate into Phase 2 trials. The biotech is initially targeting a rare but life-threatening blood disorder, and believes its drug platform represents a multi-billion market. The company boasts premier biotech backers NEA, Morgenthaler, Novartis, Novo and RA Capital; insiders have indicated on 40% of the deal.
A $400 million blank check
Formed by the former CEOs of Accenture and EMC,
GTY Technology Holdings
) is set to be one of the year's largest SPAC IPOs with a target of $400 million. It increased the deal size from $300 million, a signal of demand that no other SPAC this year has shown. However, SPACs typically begin trading near the offer price.
IPO Market Snapshot
The Renaissance IPO Indices are market cap weighted baskets of newly public companies. The Renaissance IPO Index gained 2.1% this past week compared to the S&P's +0.4%, though the IPO Index's year-to-date gain of 0.5% still trails the S&P's 5%. Renaissance Capital's
(NYSE: IPO) tracks the index, and
top ETF holdings
include Alibaba (
) and Citizens Financial Group (
). The Renaissance International IPO Index is down 2% year-to-date, while ACWX is up 4%. Renaissance Capital’s International
(NYSE: IPOS) tracks the index, and
top ETF holdings
include Recruit Holdings and Cheil Industries.
To find out if this is the best ETF for you, visit our
IPO Investing page
Keywords / Tickers:
Recently Priced IPOs
ETF Express Award:
ETFExpress awards are based on a 'peer review system' whereby readers - including institutional and high net worth investors as well as managers and other industry professionals at fund administrators, brokers, custodians and advisers - are invited to elect a 'best in class' in a series of categories via an online survey. In each category, the firms with the most votes at the end of the voting period are subject to a final review by ETFExpress's Senior Editorial team.
Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than the original cost. Investors should consider the investment objectives, risks, charges and expenses carefully before investing.
As stated in the Prospectus, the total annual operating expenses for the Fund was 3.48%. The Adviser has contractually agreed to keep net expenses from exceeding 2.50% of the Fund's average daily net assets for at least a year from the date of the Prospectus and for an indefinite period thereafter subject to annual re-approval of the agreement by the Board of Trustees.
An investor cannot invest directly in an index. Index returns do not represent Fund returns. The Index does not charge management fees or brokerage expenses, nor does the Index lend securities, and no revenues from securities lending were added to the performance shown.
Definitions: Net Asset Value (NAV) of the fund is calculated by dividing the total value of all the securities in its portfolio, less any liabilities, by the number of fund shares outstanding. Market Price is current value at which an asset or service can be bought or sold. Premium/Discount is provided to show the comparison of the daily net asset value (NAV) and the midpoint of the closing bid/ask for each of the funds.
Renaissance IPO Index® (IPOUSA)
is a stock market index based upon a portfolio of U.S.-listed newly public companies that includes securities prior to their inclusion in core U.S. equity portfolios.
Renaissance International IPO Index® (IPOXUS)
is a stock market index based upon a portfolio of newly public companies listed on non-U.S. exchanges.
The S&P 500® Index (SPX) is a stock market index which includes 500 U.S. listed companies and seeks to capture approximately 80% coverage of available U.S. market capitalization.
Risk Disclosure: Investments in the
Renaissance IPO ETF, symbol "IPO"
Renaissance International IPO ETF, symbol "IPOS"
(the "ETFs"), and the
Global IPO Fund, symbol "IPOSX"
(the "Mutual Fund") are subject to investment risk, including possible loss of the principal amounts invested. The ETFs and the Mutual Fund (the "Funds") invest in companies that have recently completed initial public offerings. These stocks are unseasoned equities lacking trading history, a track record of reporting to investors and widely available research coverage which many result in extreme price volatility. Due to a greater number of IPOs in certain segments, the Funds may also be subject to information technology and financial sector risk, small and mid-capitalization company risk, and, for the Renaissance International IPO ETF, emerging markets risk. The Funds may hold securities in the form of Depository Receipts, REITs, and Partnership Units which have greater risks than common shares. The strategies have high portfolio turnover and securities lending risks. The returns of the ETFs may not match the return of the respective indices. The ETFs are classified as non-diversified investment companies subject to concentration risk.
Prospectus: Investors should consider the investment objectives, risks, charges and expenses carefully before investing. For a prospectus and/or summary prospectus with this and other information, please visit
. Read the prospectus carefully before investing. Renaissance Capital Investments, Inc., distributor for the Mutual Fund. Foreside Fund Services, LLC, distributor for the ETFs, 1-866-486-6645.
Definitions: The Renaissance IPO Index® is a stock market index based upon a portfolio of U.S.-listed newly public companies that includes securities prior to their inclusion in core U.S. equity portfolios. The S&P 500® Index is a stock market index based on the market capitalizations of 500 large companies whose common stock is publicly traded on the NYSE or Nasdaq.
The information contained herein is proprietary and copyrighted. The media is welcome to use our information and ideas, provided that the following sourcing is included: Renaissance Capital - manager of IPO-focused ETFs.
The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital, the Renaissance IPO ETF (symbol: IPO), the Renaissance International IPO ETF (symbol: IPOS), or the Global IPO Fund (symbol: IPOSX), may have investments in securities of companies mentioned.
Register for Updates
Renaissance Capital LLC is an SEC-registered investment adviser.
Renaissance Capital Investments, Inc. is a
-registered broker-dealer, and member of
© 2016 Renaissance Capital LLC. All rights reserved.